• Something wrong with this record ?

Preparation and the kinetic stability of hyaluronan radiolabeled with 111In, 125I and 14C

D. Cozikova, A. Laznickova, M. Hermannova, E. Svanovsky, L. Palek, R. Buffa, P. Sedova, R. Koppova, M. Petrik, D. Smejkalova, M. Laznicek, V. Velebny,

. 2010 ; 52 (4) : 517-24. [pub] 20100211

Language English Country England, Great Britain

Document type Comparative Study, Journal Article

Three different procedures for the labeling of hyaluronan (HA) with (111)In, (125)I and (14)C radionuclides were compared, and the kinetic stability of radiolabeled HA under different conditions (saline, artificial gastric juice and plasma) was established. Modification of HA structure with bifunctional chelating agents (DTPA) or with the prosthetic group (tyramine or tyrosine) was essential prior (111)In and (125)I labeling. These chemical labeling techniques were fast, simple and inexpensive, and labeled agents with a high specific activity were obtained. The only disadvantage of these methods was the occurrence of unknown functional groups in the HA molecule requiring further characterization of the compound. Conversely, HA labeling with (14)C by biotechnological synthesis was found to be rather expensive and time-consuming process. Although, the final product (14)C-HA was identical to natural HA its low specific activity presents certain limitation for its application in biological experiments. Stability studies showed that (14)C-HA and (125)I-Tm-HA were stable in all studied mediums. In the case of (125)I-Trs-HA, stability slightly decreased in rat plasma and in artificial gastric juice with increasing time. The least stable was (111)In-DTPA-HA, which degraded completely after 48h in artificial gastric juice. Kinetic stability studies may provide primary information concerning the properties of radiolabeled HA in vitro, which is essential for the use and explanation of its behavior in biological experiments.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026460
003      
CZ-PrNML
005      
20250318144359.0
007      
ta
008      
120817s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2010.02.005 $2 doi
035    __
$a (PubMed)20189740
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Cozikova, D $u Contipro C a.s., Dolni Dobrouc 401, 561 02 Dolni Dobrouc, Czech Republic. cozikova@contipro.cz
245    10
$a Preparation and the kinetic stability of hyaluronan radiolabeled with 111In, 125I and 14C / $c D. Cozikova, A. Laznickova, M. Hermannova, E. Svanovsky, L. Palek, R. Buffa, P. Sedova, R. Koppova, M. Petrik, D. Smejkalova, M. Laznicek, V. Velebny,
520    9_
$a Three different procedures for the labeling of hyaluronan (HA) with (111)In, (125)I and (14)C radionuclides were compared, and the kinetic stability of radiolabeled HA under different conditions (saline, artificial gastric juice and plasma) was established. Modification of HA structure with bifunctional chelating agents (DTPA) or with the prosthetic group (tyramine or tyrosine) was essential prior (111)In and (125)I labeling. These chemical labeling techniques were fast, simple and inexpensive, and labeled agents with a high specific activity were obtained. The only disadvantage of these methods was the occurrence of unknown functional groups in the HA molecule requiring further characterization of the compound. Conversely, HA labeling with (14)C by biotechnological synthesis was found to be rather expensive and time-consuming process. Although, the final product (14)C-HA was identical to natural HA its low specific activity presents certain limitation for its application in biological experiments. Stability studies showed that (14)C-HA and (125)I-Tm-HA were stable in all studied mediums. In the case of (125)I-Trs-HA, stability slightly decreased in rat plasma and in artificial gastric juice with increasing time. The least stable was (111)In-DTPA-HA, which degraded completely after 48h in artificial gastric juice. Kinetic stability studies may provide primary information concerning the properties of radiolabeled HA in vitro, which is essential for the use and explanation of its behavior in biological experiments.
650    _2
$a zvířata $7 D000818
650    _2
$a radioizotopy uhlíku $x chemie $x farmakokinetika $7 D002250
650    _2
$a stabilita léku $7 D004355
650    _2
$a kyselina hyaluronová $x chemická syntéza $x farmakokinetika $7 D006820
650    _2
$a radioizotopy india $x chemie $x farmakokinetika $7 D007205
650    _2
$a radioizotopy jodu $x chemie $x farmakokinetika $7 D007457
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Laznickova, A
700    1_
$a Hermannova, M
700    1_
$a Svanovsky, E
700    1_
$a Palek, L
700    1_
$a Buffa, Radovan $7 xx0330178
700    1_
$a Sedova, P
700    1_
$a Koppova, R
700    1_
$a Petrik, M
700    1_
$a Smejkalova, D
700    1_
$a Laznicek, M
700    1_
$a Velebny, V
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 52, č. 4 (2010), s. 517-24
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20189740 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20250318144356 $b ABA008
999    __
$a ok $b bmc $g 948502 $s 783806
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 52 $c 4 $d 517-24 $e 20100211 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20120817/10/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...